Difficulty: Medium
Average Score: 67%
Practice
Following chemotherapy, a patient is being closely monitored for tumor lysis syndrome. Which laboratory value requires particular attention?
Correct answer
B
Rationale
In the context of a patient undergoing chemotherapy and being monitored for tumor lysis syndrome, electrolytes require particular attention. Tumor lysis syndrome is characterized by a rapid release of intracellular contents into the bloodstream, leading to metabolic disturbances, including hyperkalemia, hyperphosphatemia, hypocalcemia, and hyperuricemia. Monitoring electrolyte levels is crucial to detect and manage these imbalances promptly to prevent complications like cardiac arrhythmias, renal failure, and seizures.
Platelet count, hemoglobin, and hematocrit are important parameters to monitor in cancer patients undergoing chemotherapy, but they are not specifically indicative of tumor lysis syndrome. Platelet count is essential for assessing bleeding risk, while hemoglobin and hematocrit levels provide information about the patient's oxygen-carrying capacity. However, in the context of tumor lysis syndrome, electrolyte abnormalities are a more immediate concern due to their potential to cause life-threatening complications.
Educationally, understanding the significance of electrolyte monitoring in tumor lysis syndrome highlights the importance of recognizing and managing oncologic emergencies. It emphasizes the need for vigilant assessment and intervention to prevent serious consequences associated with metabolic imbalances in these high-risk patients. This knowledge is essential for nurses and healthcare providers caring for oncology patients to ensure timely and appropriate interventions.
Platelet count, hemoglobin, and hematocrit are important parameters to monitor in cancer patients undergoing chemotherapy, but they are not specifically indicative of tumor lysis syndrome. Platelet count is essential for assessing bleeding risk, while hemoglobin and hematocrit levels provide information about the patient's oxygen-carrying capacity. However, in the context of tumor lysis syndrome, electrolyte abnormalities are a more immediate concern due to their potential to cause life-threatening complications.
Educationally, understanding the significance of electrolyte monitoring in tumor lysis syndrome highlights the importance of recognizing and managing oncologic emergencies. It emphasizes the need for vigilant assessment and intervention to prevent serious consequences associated with metabolic imbalances in these high-risk patients. This knowledge is essential for nurses and healthcare providers caring for oncology patients to ensure timely and appropriate interventions.